EP3169709
CRYSTALLINE ANTIBODY FORMULATIONS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
13.7.2015EP published:
12.5.2021EP application number:
15739763.9
EPO information:
European Patent Register
Max expiry date:
12.7.2035
Title:
CRYSTALLINE ANTIBODY FORMULATIONS
Timeline
Today
13.7.2015EP application
12.5.2021EP Publication
Owner
Name:
Amgen Inc.Address:
One Amgen Center Drive, Thousand Oaks, California 91320-1799, US
Inventor
Name:
TWINKLE, Christian R.Address:
Thousand Oaks, CA 91361, US
Name:
CLOGSTON, Christi L.Address:
Camarillo, CA 93010, US
Name:
OSSLUND, Timothy DavidAddress:
Camarillo, CA 93010, US
Priority
Number:
201462024399 PDate:
14.7.2014Country:
US
Classification
Categories:
C07K 16/40